J Bacteriol Virol.  2011 Sep;41(3):209-212. 10.4167/jbv.2011.41.3.209.

The Development of Anti-inflammatory Drugs for Viral Diseases

• Kim YW

• KMID: 1449897
• DOI: http://doi.org/10.4167/jbv.2011.41.3.209

Abstract

Viral disease is traditionally thought to result from an insufficient response of the host to infection, leading to increased replication of viruses and consequently disease. However, the disease is not the simple result of uncontrolled replication of virus. Indeed, the inflammatory response triggered by certain infection is frequently the cause of tissue damage and death. This inflammatory situation can be called as immunopathologic phenomena. By understanding the mechanisms which drive disease, novel therapies may be devised for treatment of patients. I will describe the situations of some viral diseases in which unwanted (excessive, misplaced or altered) inflammation causes immunopathologic phenomena and is responsible for disease induction. In these situations, I will also describe some candidates of antiviral drug which inhibit or modulate the inflammatory response to viral infection.

Keyword

Anti-inflammatory drug; Viral disease; Immunopathologic phenomena

MeSH Terms

Humans
Inflammation
Virus Diseases
Viruses

Reference

1. Garcia CC, Guabiraba R, Soriani FM, Teixeira MM. The development of anti-inflammatory drugs for infectious diseases. Discov Med. 2010. 10:479–488.

2. Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection. Pathol Biol. 2010. 58:258–266.

3. Grimm D, Thimme R, Blum HE. HBV life cycle and novel drug targets. Hepatol Int. 2011. 5:644–653.

4. Krilov LR. Respiratory syncytial virus disease: update on treatment and prevention. Expert Rev Anti Infect Ther. 2011. 9:27–32.

5. Vezali E, Aghemo A, Colombo M. Interferon in the treatment of chronic hepatitis C: a drug caught between past and future. Expert Opin Biol Ther. 2011. 11:301–313.

6. Lo AW, Nalson LST, Ka-Fai T. How the SARS coronavirus causes disease: host or organism? J Pathol. 2006. 208:142–151.

7. Kim YW, Kim YJ, Choi YH, Ahn JY, Woo SD, Sin SW, et al. Novel anti-viral VSF protein and hybridoma producing the same. US patent. US 7,514.082 B2. 2009.